Synergistic Antimicrobial Effects of Cefabronchin.

Antibiotic resistance of has risen to worrying levels in the past few decades worldwide, and subsequently, effective treatment of respiratory tract infections has become even more challenging. While the need to develop new strategies to combat bacterial infections is urgent, novel antibiotic compounds are no longer a priority of the pharmaceutical industry. However, resistance-modifying agents can alleviate the spread of antibiotic resistance and render existing antibiotics effective again. In the present study, we aimed to determine the combinatory antimicrobial effects of the commercial herbal product Cefabronchin and antibiotic compounds, such as amoxicillin and clarithromycin, on 6 clinical isolates of Therefore, the minimal inhibitory concentration (MIC) of each agent before and after adding Cefabronchin at different concentrations was determined by applying the checkerboard method. Sub-inhibitory concentrations of the added Cefabronchin were found to reduce the MIC down to between 3.4% and 29.2% of the amoxicillin MIC and down to between 10.4% and 45.8% of the clarithromycin MIC in all 6 strains. In conclusion, this study provides evidence for the improved antimicrobial effects of commonly used antibiotics in combination with Cefabronchin in order to combat infections with antibiotic-resistant strains.